Please Wait.....
Report
Drug-Eluting Stents Market Report by Coating (Polymer Based Coating, Polymer Free Coating), Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, and Others), Stent Platform (Stainless-steel, Cobalt-Chromium, Platinum-Chromium, Nitinol, and Others), Generation (1st Generation, 2nd Generation, 3rd Generation, 4th Generation), Application (Coronary Artery Disease, Peripheral Artery Disease), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region ?2026-2034?
Market Report I 2026-03-01 I 148 Pages I IMARC Group
The global drug-eluting stents marketsize reached USD 9.2 Billion in 2025. Looking forward, the market is expected to reach USD 14.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.03% during 2026-2034. The increasing prevalence of cardiovascular diseases is propelling the market.
DRUG-ELUTING STENTS MARKET ANALYSIS:
- Major Market Drivers: The increasing prevalence of irregular heart rhythms, heart failure, and heart attack disease is stimulating the market.
- Key Market Trends: The widespread use of stents with polymer-free coatings is acting as a significant growth-inducing factor.
- Competitive Landscape: Some of the major market companies include Abbott, B. Braun SE, Biosensors International Group, Ltd., Biotronik, Boston Scientific Corporation, Cook Medical, Lepu Medical Technology (Beijing) Co., Ltd, Medinol, Medtronic plc, MicroPort Scientific Corporation, Sino Medical Sciences Technology Inc and Terumo Corporation, among many others.
- Geographical Trends: North America dominates the market owing to arobust healthcare system, rising incidence of coronary artery disease, and extensive use of innovative medical technologies.
- Challenges and Opportunities: The risk of late stent thrombosis is hampering the market. However, developing innovative stent technologies with greater biocompatibility and polymer-free coatings to increase patient safety is expected to fuel the market in the coming years.
DRUG-ELUTING STENTS MARKET TRENDS:
Implementation of Next-Generation Drugs
The next generationof drug-eluting stents usesadvanced medications, such as biolimus and zotarolimus, which have higher efficacy in preventing restenosis while reducing adverse effects, making these stents more useful for a wider variety of patients. For example, in May 2024, Abbott announced the launch of XIENCE Sierra Everolimus (drug) eluting coronary stent system in India. It is a CE-marked and one of the latest generation stents in the XIENCE family, now available to people suffering from blocked coronary arteries. This is leading to the drug-eluting stents market growth.
Expanded Use in Peripheral Artery Disease
Drug-eluting stents are being increasingly utilized to treat peripheral arterial disease (PAD), moving beyond coronary applications. This trend reflects stents' growing use in treating blockages in arteries beyond the heart. In April 2024, Cook Medical received a contract to supply implantable devices to hospitals run by the U.S. Department of Defense (DoD). The company would provide its Zilver PTX drug-eluting peripheral stent, Zenith aortic endograft, and other implantable devices. This is expanding the drug-eluting stents market share.
Increasing Focus on Complex Lesions
Drug-eluting stents are in high demand for treating complicated coronary lesions such as bifurcation and multi-vessel disease. These advanced stents are designed to handle complex anatomical issues with more precision. In June 2024, Elixir Medical's DynamX Sirolimus-Eluting Coronary Bioadaptor System received Breakthrough Device Designation from the FDA. This bioadaptive implant aims to improve coronary luminal diameter, restore hemodynamic modulation, and reduce plaque progression in patients with symptomatic ischemic heart disease.
GLOBAL DRUG-ELUTING STENTS INDUSTRY SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with the drug-eluting stents market forecast at the global, regional, and country levels for 2026-2034. Our report has categorized the market based on the coating, drug, stent platform, generation, application, and end user.
Breakup by Coating:
- Polymer Based Coating
- Polymer Free Coating
Among these, polymer free coating holds the largest share of the drug-eluting stents market
The report has provided a detailed breakup and analysis of the market based on the coating. This includespolymer based coating and polymer free coating.According to the report, polymer free coating represented the largest market segmentation.
Polymer free coating is intended to minimize inflammation and promote healing. These coatings improve medication delivery while eliminating the problems associated with polymers, resulting in better patient outcomes during cardiovascular treatments. This is elevating the drug-eluting stents market revenue.
Breakup by Drug:
- Sirolimus
- Paclitaxel
- Zotarolimus
- Everolimus
- Biolimus
- Others
The report has provided a detailed breakup and analysis of the market based on the drug. This includessirolimus, paclitaxel, zotarolimus, everolimus, biolimus, and others.
The drug-eluting stents market overview highlights that sirolimus reduces cell development to avoid arterial narrowing, whilepaclitaxel inhibits cell division, resulting in better blood flow. Zotarolimus enhances healing while causing less adverse effects, and everolimus has been shown to reduce re-narrowing over time. Biolimus, a biodegradable alternative, promotes vascular recovery, providing a variety of therapy options in the market.
Breakup by Stent Platform:
- Stainless-steel
- Cobalt-Chromium
- Platinum-Chromium
- Nitinol
- Others
Cobalt-chromium currently holds the largest drug-eluting stents market demand
The report has provided a detailed breakup and analysis of the market based on the stent platform. This includes stainless-steel, cobalt-chromium,platinum-chromium, nitinol, and others. According to the report, cobalt-chromium represented the largest market segmentation.
Cobalt-chromium stents are well-known for their long-lasting, flexible, and biocompatible design. These stents have a sturdy construction but allow for thinner struts, which improves vessel support and reduces problems during cardiovascular treatments. This is elevating the drug-eluting stents market statistics.
Breakup by Generation:
- 1st Generation
- 2nd Generation
- 3rd Generation
- 4th Generation
The report has provided a detailed breakup and analysis of the market based on the generation. This includes1st generation, 2nd generation, 3rd generation, and 4th generation.
The 1stgeneration drug-eluting stents used basic drug coatings to minimize restenosis. The 2nd generation increased safety by improving biocompatibility and using thinner struts. The 3rdgeneration focused on biodegradable polymers to improve healing, while the 4thgeneration uses polymer-free coatings to promote speedier recovery and reduce inflammation. Each generation represents advances in safety, efficacy, and patient outcomes.
Breakup by Application:
- Coronary Artery Disease
- Peripheral Artery Disease
Currently, coronary artery disease holds the largest share of the drug-eluting stents market recent price
The report has provided a detailed breakup and analysis of the market based on the application. This includes coronary artery disease andperipheral artery disease. According to the report, coronary artery disease represented the largest market segmentation.
The market largely focuses on coronary artery disease by releasing medications that prevent restenosis. These stents help to maintain artery patency, improve blood flow, and reduce the need for repeat treatments in patients with blocked or narrowed arteries.
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
Among these, hospitals currently hold the largest share of the market
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, ambulatorysurgical centers, and others. According to the report, hospitals represented the largest market segmentation.
Hospitals are the primary end users in this market, as these devices are commonly utilized in cardiovascular surgeries to treat coronary artery disease. These stents are used in hospitals to improve patient outcomes, lower restenosis, and reduce the need for recurrent treatments. This represents one of the drug-eluting stents market recent opportunities.
Breakup by Region:
- North America
o United States
o Canada
- Asia-Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others
- Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others
- Latin America
o Brazil
o Mexico
o Others
- Middle East and Africa
North America currently dominates the drug-eluting stents market outlook
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America exhibits a clear dominance in the market. This can be attributed to the enhanced healthcare infrastructure, a high prevalence of cardiovascular illnesses, and the growing adoption of cutting-edge stent technology. The region's focus on reducing coronary artery disease promotes demand for these devices.
COMPETITIVE LANDSCAPE:
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major drug-eluting stents market companies have also been provided. Some of the key players in the market include:
- Abbott
- B. Braun SE
- Biosensors International Group, Ltd.
- Biotronik
- Boston Scientific Corporation
- Cook Medical
- Lepu Medical Technology (Beijing) Co., Ltd
- Medinol
- Medtronic plc
- MicroPort Scientific Corporation
- Sino Medical Sciences Technology Inc
- Terumo Corporation
()
KEY QUESTIONS ANSWERED IN THIS REPORT
1. What was the size of the global drug-eluting stents market in 2025?
2. What is the expected growth rate of the global drug-eluting stents market during 2026-2034?
3. What are the key factors driving the global drug-eluting stents market?
4. What has been the impact of COVID-19 on the global drug-eluting stents market?
5. What is the breakup of the global drug-eluting stents market based on the coating?
6. What is the breakup of the global drug-eluting stents market based on the stent platform?
7. What is the breakup of the global drug-eluting stents market based on application?
8. What is the breakup of the global drug-eluting stents market based on the end user?
9. What are the key regions in the global drug-eluting stents market?
10. Who are the key players/companies in the global drug-eluting stents market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Drug-Eluting Stents Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Coating
6.1 Polymer Based Coating
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Polymer Free Coating
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug
7.1 Sirolimus
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Paclitaxel
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Zotarolimus
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Everolimus
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Biolimus
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Stent Platform
8.1 Stainless-steel
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cobalt-Chromium
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Platinum-Chromium
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Nitinol
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Generation
9.1 1st Generation
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 2nd Generation
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 3rd Generation
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 4th Generation
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Application
10.1 Coronary Artery Disease
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Peripheral Artery Disease
10.2.1 Market Trends
10.2.2 Market Forecast
11 Market Breakup by End User
11.1 Hospitals
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Ambulatory Surgical Centers
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Others
11.3.1 Market Trends
11.3.2 Market Forecast
12 Market Breakup by Region
12.1 North America
12.1.1 United States
12.1.1.1 Market Trends
12.1.1.2 Market Forecast
12.1.2 Canada
12.1.2.1 Market Trends
12.1.2.2 Market Forecast
12.2 Asia-Pacific
12.2.1 China
12.2.1.1 Market Trends
12.2.1.2 Market Forecast
12.2.2 Japan
12.2.2.1 Market Trends
12.2.2.2 Market Forecast
12.2.3 India
12.2.3.1 Market Trends
12.2.3.2 Market Forecast
12.2.4 South Korea
12.2.4.1 Market Trends
12.2.4.2 Market Forecast
12.2.5 Australia
12.2.5.1 Market Trends
12.2.5.2 Market Forecast
12.2.6 Indonesia
12.2.6.1 Market Trends
12.2.6.2 Market Forecast
12.2.7 Others
12.2.7.1 Market Trends
12.2.7.2 Market Forecast
12.3 Europe
12.3.1 Germany
12.3.1.1 Market Trends
12.3.1.2 Market Forecast
12.3.2 France
12.3.2.1 Market Trends
12.3.2.2 Market Forecast
12.3.3 United Kingdom
12.3.3.1 Market Trends
12.3.3.2 Market Forecast
12.3.4 Italy
12.3.4.1 Market Trends
12.3.4.2 Market Forecast
12.3.5 Spain
12.3.5.1 Market Trends
12.3.5.2 Market Forecast
12.3.6 Russia
12.3.6.1 Market Trends
12.3.6.2 Market Forecast
12.3.7 Others
12.3.7.1 Market Trends
12.3.7.2 Market Forecast
12.4 Latin America
12.4.1 Brazil
12.4.1.1 Market Trends
12.4.1.2 Market Forecast
12.4.2 Mexico
12.4.2.1 Market Trends
12.4.2.2 Market Forecast
12.4.3 Others
12.4.3.1 Market Trends
12.4.3.2 Market Forecast
12.5 Middle East and Africa
12.5.1 Market Trends
12.5.2 Market Breakup by Country
12.5.3 Market Forecast
13 SWOT Analysis
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats
14 Value Chain Analysis
15 Porters Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 Price Analysis
17 Competitive Landscape
17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
17.3.1 Abbott
17.3.1.1 Company Overview
17.3.1.2 Product Portfolio
17.3.1.3 Financials
17.3.1.4 SWOT Analysis
17.3.2 B. Braun SE
17.3.2.1 Company Overview
17.3.2.2 Product Portfolio
17.3.2.3 SWOT Analysis
17.3.3 Biosensors International Group, Ltd.
17.3.3.1 Company Overview
17.3.3.2 Product Portfolio
17.3.4 Biotronik
17.3.4.1 Company Overview
17.3.4.2 Product Portfolio
17.3.4.3 SWOT Analysis
17.3.5 Boston Scientific Corporation
17.3.5.1 Company Overview
17.3.5.2 Product Portfolio
17.3.5.3 Financials
17.3.5.4 SWOT Analysis
17.3.6 Cook Medical
17.3.6.1 Company Overview
17.3.6.2 Product Portfolio
17.3.6.3 SWOT Analysis
17.3.7 Lepu Medical Technology (Beijing) Co., Ltd
17.3.7.1 Company Overview
17.3.7.2 Product Portfolio
17.3.7.3 Financials
17.3.8 Medinol
17.3.8.1 Company Overview
17.3.8.2 Product Portfolio
17.3.8.3 Financials
17.3.8.4 SWOT Analysis
17.3.9 Medtronic plc
17.3.9.1 Company Overview
17.3.9.2 Product Portfolio
17.3.9.3 Financials
17.3.9.4 SWOT Analysis
17.3.10 MicroPort Scientific Corporation
17.3.10.1 Company Overview
17.3.10.2 Product Portfolio
17.3.11 Sino Medical Sciences Technology Inc
17.3.11.1 Company Overview
17.3.11.2 Product Portfolio
17.3.12 Terumo Corporation
17.3.12.1 Company Overview
17.3.12.2 Product Portfolio
17.3.12.3 Financials
17.3.12.4 SWOT Analysis
Figure 1: Global: Drug-Eluting Stents Market: Major Drivers and Challenges
Figure 2: Global: Drug-Eluting Stents Market: Sales Value (in Billion USD), 2020-2025
Figure 3: Global: Drug-Eluting Stents Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 4: Global: Drug-Eluting Stents Market: Breakup by Coating (in %), 2025
Figure 5: Global: Drug-Eluting Stents Market: Breakup by Drug (in %), 2025
Figure 6: Global: Drug-Eluting Stents Market: Breakup by Stent Platform (in %), 2025
Figure 7: Global: Drug-Eluting Stents Market: Breakup by Generation (in %), 2025
Figure 8: Global: Drug-Eluting Stents Market: Breakup by Application (in %), 2025
Figure 9: Global: Drug-Eluting Stents Market: Breakup by End User (in %), 2025
Figure 10: Global: Drug-Eluting Stents Market: Breakup by Region (in %), 2025
Figure 11: Global: Drug-Eluting Stents (Polymer Based Coating) Market: Sales Value (in Million USD), 2020 & 2025
Figure 12: Global: Drug-Eluting Stents (Polymer Based Coating) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 13: Global: Drug-Eluting Stents (Polymer Free Coating) Market: Sales Value (in Million USD), 2020 & 2025
Figure 14: Global: Drug-Eluting Stents (Polymer Free Coating) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 15: Global: Drug-Eluting Stents (Sirolimus) Market: Sales Value (in Million USD), 2020 & 2025
Figure 16: Global: Drug-Eluting Stents (Sirolimus) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 17: Global: Drug-Eluting Stents (Paclitaxel) Market: Sales Value (in Million USD), 2020 & 2025
Figure 18: Global: Drug-Eluting Stents (Paclitaxel) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 19: Global: Drug-Eluting Stents (Zotarolimus) Market: Sales Value (in Million USD), 2020 & 2025
Figure 20: Global: Drug-Eluting Stents (Zotarolimus) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 21: Global: Drug-Eluting Stents (Everolimus) Market: Sales Value (in Million USD), 2020 & 2025
Figure 22: Global: Drug-Eluting Stents (Everolimus) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 23: Global: Drug-Eluting Stents (Biolimus) Market: Sales Value (in Million USD), 2020 & 2025
Figure 24: Global: Drug-Eluting Stents (Biolimus) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 25: Global: Drug-Eluting Stents (Other Drugs) Market: Sales Value (in Million USD), 2020 & 2025
Figure 26: Global: Drug-Eluting Stents (Other Drugs) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 27: Global: Drug-Eluting Stents (Stainless-steel) Market: Sales Value (in Million USD), 2020 & 2025
Figure 28: Global: Drug-Eluting Stents (Stainless-steel) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 29: Global: Drug-Eluting Stents (Cobalt-Chromium) Market: Sales Value (in Million USD), 2020 & 2025
Figure 30: Global: Drug-Eluting Stents (Cobalt-Chromium) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 31: Global: Drug-Eluting Stents (Platinum-Chromium) Market: Sales Value (in Million USD), 2020 & 2025
Figure 32: Global: Drug-Eluting Stents (Platinum-Chromium) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 33: Global: Drug-Eluting Stents (Nitinol) Market: Sales Value (in Million USD), 2020 & 2025
Figure 34: Global: Drug-Eluting Stents (Nitinol) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 35: Global: Drug-Eluting Stents (Other Stent Platforms) Market: Sales Value (in Million USD), 2020 & 2025
Figure 36: Global: Drug-Eluting Stents (Other Stent Platforms) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 37: Global: Drug-Eluting Stents (1st Generation) Market: Sales Value (in Million USD), 2020 & 2025
Figure 38: Global: Drug-Eluting Stents (1st Generation) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 39: Global: Drug-Eluting Stents (2nd Generation) Market: Sales Value (in Million USD), 2020 & 2025
Figure 40: Global: Drug-Eluting Stents (2nd Generation) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 41: Global: Drug-Eluting Stents (3rd Generation) Market: Sales Value (in Million USD), 2020 & 2025
Figure 42: Global: Drug-Eluting Stents (3rd Generation) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 43: Global: Drug-Eluting Stents (4th Generation) Market: Sales Value (in Million USD), 2020 & 2025
Figure 44: Global: Drug-Eluting Stents (4th Generation) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 45: Global: Drug-Eluting Stents (Coronary Artery Disease) Market: Sales Value (in Million USD), 2020 & 2025
Figure 46: Global: Drug-Eluting Stents (Coronary Artery Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 47: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market: Sales Value (in Million USD), 2020 & 2025
Figure 48: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 49: Global: Drug-Eluting Stents (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
Figure 50: Global: Drug-Eluting Stents (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 51: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2020 & 2025
Figure 52: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 53: Global: Drug-Eluting Stents (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
Figure 54: Global: Drug-Eluting Stents (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 55: North America: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 56: North America: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 57: United States: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 58: United States: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 59: Canada: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 60: Canada: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 61: Asia-Pacific: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 62: Asia-Pacific: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 63: China: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 64: China: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 65: Japan: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 66: Japan: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 67: India: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 68: India: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 69: South Korea: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 70: South Korea: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 71: Australia: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 72: Australia: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 73: Indonesia: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 74: Indonesia: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 75: Others: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 76: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 77: Europe: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 78: Europe: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 79: Germany: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 80: Germany: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 81: France: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 82: France: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 83: United Kingdom: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 84: United Kingdom: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 85: Italy: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 86: Italy: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 87: Spain: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 88: Spain: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 89: Russia: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 90: Russia: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 91: Others: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 92: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 93: Latin America: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 94: Latin America: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 95: Brazil: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 96: Brazil: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 97: Mexico: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 98: Mexico: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 99: Others: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 100: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 101: Middle East and Africa: Drug-Eluting Stents Market: Sales Value (in Million USD), 2020 & 2025
Figure 102: Middle East and Africa: Drug-Eluting Stents Market: Breakup by Country (in %), 2025
Figure 103: Middle East and Africa: Drug-Eluting Stents Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 104: Global: Drug-Eluting Stents Industry: SWOT Analysis
Figure 105: Global: Drug-Eluting Stents Industry: Value Chain Analysis
Figure 106: Global: Drug-Eluting Stents Industry: Porter's Five Forces Analysis
Table 1: Global: Drug-Eluting Stents Market: Key Industry Highlights, 2025 and 2034
Table 2: Global: Drug-Eluting Stents Market Forecast: Breakup by Coating (in Million USD), 2026-2034
Table 3: Global: Drug-Eluting Stents Market Forecast: Breakup by Drug (in Million USD), 2026-2034
Table 4: Global: Drug-Eluting Stents Market Forecast: Breakup by Stent Platform (in Million USD), 2026-2034
Table 5: Global: Drug-Eluting Stents Market Forecast: Breakup by Generation (in Million USD), 2026-2034
Table 6: Global: Drug-Eluting Stents Market Forecast: Breakup by Application (in Million USD), 2026-2034
Table 7: Global: Drug-Eluting Stents Market Forecast: Breakup by End User (in Million USD), 2026-2034
Table 8: Global: Drug-Eluting Stents Market Forecast: Breakup by Region (in Million USD), 2026-2034
Table 9: Global: Drug-Eluting Stents Market: Competitive Structure
Table 10: Global: Drug-Eluting Stents Market: Key Players
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security